Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VISTA PHARMA vs IPCA LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VISTA PHARMA IPCA LABS VISTA PHARMA/
IPCA LABS
 
P/E (TTM) x -6.0 51.7 - View Chart
P/BV x 1.7 5.4 30.9% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 VISTA PHARMA   IPCA LABS
EQUITY SHARE DATA
    VISTA PHARMA
Mar-23
IPCA LABS
Mar-23
VISTA PHARMA/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs141,062 1.4%   
Low Rs7768 0.8%   
Sales per share (Unadj.) Rs0.3243.0 0.1%  
Earnings per share (Unadj.) Rs-1.519.4 -7.8%  
Cash flow per share (Unadj.) Rs-1.329.7 -4.5%  
Dividends per share (Unadj.) Rs04.00 0.0%  
Avg Dividend yield %00.4 0.0%  
Book value per share (Unadj.) Rs8.1230.3 3.5%  
Shares outstanding (eoy) m37.56253.70 14.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x39.13.8 1,039.3%   
Avg P/E ratio x-6.947.2 -14.7%  
P/CF ratio (eoy) x-7.830.8 -25.3%  
Price / Book Value ratio x1.34.0 32.4%  
Dividend payout %020.6 -0.0%   
Avg Mkt Cap Rs m393232,120 0.2%   
No. of employees `000NANA-   
Total wages/salary Rs m512,876 0.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1061,642 0.0%  
Other income Rs m41,518 0.3%   
Total revenues Rs m1463,160 0.0%   
Gross profit Rs m-449,033 -0.5%  
Depreciation Rs m62,616 0.2%   
Interest Rs m12482 2.5%   
Profit before tax Rs m-597,453 -0.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-22,534 -0.1%   
Profit after tax Rs m-574,919 -1.2%  
Gross profit margin %-442.714.7 -3,021.1%  
Effective tax rate %3.634.0 10.7%   
Net profit margin %-563.98.0 -7,066.6%  
BALANCE SHEET DATA
Current assets Rs m23851,893 0.5%   
Current liabilities Rs m14118,058 0.8%   
Net working cap to sales %963.054.9 1,754.4%  
Current ratio x1.72.9 58.7%  
Inventory Days Days20751 403.4%  
Debtors Days Days40,9026 698,433.7%  
Net fixed assets Rs m29634,336 0.9%   
Share capital Rs m75254 29.6%   
"Free" reserves Rs m23058,167 0.4%   
Net worth Rs m30658,420 0.5%   
Long term debt Rs m526,518 0.8%   
Total assets Rs m53486,229 0.6%  
Interest coverage x-3.816.5 -23.3%   
Debt to equity ratio x0.20.1 151.9%  
Sales to assets ratio x00.7 2.6%   
Return on assets %-8.36.3 -133.0%  
Return on equity %-18.58.4 -220.1%  
Return on capital %-13.112.2 -106.8%  
Exports to sales %042.9 0.0%   
Imports to sales %013.3 0.0%   
Exports (fob) Rs mNA26,434 0.0%   
Imports (cif) Rs mNA8,178 0.0%   
Fx inflow Rs m026,434 0.0%   
Fx outflow Rs m08,178 0.0%   
Net fx Rs m018,257 0.0%   
CASH FLOW
From Operations Rs m-178,058 -0.2%  
From Investments Rs m-13-7,250 0.2%  
From Financial Activity Rs m315,072 0.6%  
Net Cashflow Rs m15,881 0.0%  

Share Holding

Indian Promoters % 15.6 46.3 33.8%  
Foreign collaborators % 12.2 0.0 -  
Indian inst/Mut Fund % 0.0 44.8 0.1%  
FIIs % 0.0 10.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 72.2 53.7 134.4%  
Shareholders   13,908 82,809 16.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VISTA PHARMA With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on VISTA PHARMA vs IPCA Labs

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

VISTA PHARMA vs IPCA Labs Share Price Performance

Period VISTA PHARMA IPCA Labs S&P BSE HEALTHCARE
1-Day -2.83% 3.35% 1.18%
1-Month -22.19% 4.27% -0.75%
1-Year 28.28% 56.49% 61.82%
3-Year CAGR 4.50% 9.46% 18.16%
5-Year CAGR -11.60% 20.88% 19.79%

* Compound Annual Growth Rate

Here are more details on the VISTA PHARMA share price and the IPCA Labs share price.

Moving on to shareholding structures...

The promoters of VISTA PHARMA hold a 27.8% stake in the company. In case of IPCA Labs the stake stands at 46.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of VISTA PHARMA and the shareholding pattern of IPCA Labs.

Finally, a word on dividends...

In the most recent financial year, VISTA PHARMA paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

IPCA Labs paid Rs 4.0, and its dividend payout ratio stood at 20.6%.

You may visit here to review the dividend history of VISTA PHARMA, and the dividend history of IPCA Labs.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.